JAZZ Venture Partners is a venture capital firm focused on technologies that extend the boundaries of human performance.
JAZZ Venture Partners is the leading venture capital firm focused on technologies that extend the boundaries of human performance. They invest in companies at the intersection of digital technology and neuroscience. They are interested in companies that leverage cutting-edge brain science to inform powerful technology platforms that are impacting the human experience, such as virtual and augmented reality, immersive video gaming, artificial intelligence, and closed-loop human-computer systems. Their portfolio companies are unlocking human potential in important markets: health, mind-body wellness, peak mental and physical performance, accelerated learning and training, sports, and entertainment.The partners are proven investors, entrepreneurs, neuroscientists, and technologists. They have deep domain experience and unparalleled access to innovative companies, talent, and strategic resources. Their multidisciplinary backgrounds allow us to meaningfully support exceptional entrepreneurs and executives in building category-defining companies.
Date
Company Name
|
Round | Money Raised | Industry | Lead Investor |
---|---|---|---|---|
Dec 21, 2022
Enveda Biosciences
|
Series B | $55M | Biotechnology | — |
Mar 9, 2022
Colossal Biosciences
|
Series A | $60M | Biotechnology | — |
May 6, 2021
Colossal Biosciences
|
Seed | $15M | Biotechnology | — |
Sep 23, 2020
Freeletics
|
Series B | $25M | Apps | Yes |
Oct 11, 2019
Cadence Neuroscience
|
Series A | $15M | Health Care | Yes |